We enrolled 13 484 patients with bronchiectasis from 31 countries. Assessment of sputum colour at baseline was used to investigate the relationship with disease severity and outcomes. We show a strong relationship between sputum colour and exacerbations and hospitalisation for severe exacerbations. Increasing sputum purulence is a marker of disease outcome in bronchiectasis.